ATE346924T1 - P-glycoproteine und ihre verwendungen - Google Patents

P-glycoproteine und ihre verwendungen

Info

Publication number
ATE346924T1
ATE346924T1 AT00967072T AT00967072T ATE346924T1 AT E346924 T1 ATE346924 T1 AT E346924T1 AT 00967072 T AT00967072 T AT 00967072T AT 00967072 T AT00967072 T AT 00967072T AT E346924 T1 ATE346924 T1 AT E346924T1
Authority
AT
Austria
Prior art keywords
dog
pgp
glycoproteins
inhibitors
glycoprotein
Prior art date
Application number
AT00967072T
Other languages
English (en)
Inventor
Penny J Stocker
Dorothy T Steimel-Crespi
Charles L Crespi
Timothy C Reif
Christopher J Patten
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Application granted granted Critical
Publication of ATE346924T1 publication Critical patent/ATE346924T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00967072T 1999-09-28 2000-09-28 P-glycoproteine und ihre verwendungen ATE346924T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15651099P 1999-09-28 1999-09-28

Publications (1)

Publication Number Publication Date
ATE346924T1 true ATE346924T1 (de) 2006-12-15

Family

ID=22559872

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00967072T ATE346924T1 (de) 1999-09-28 2000-09-28 P-glycoproteine und ihre verwendungen

Country Status (7)

Country Link
EP (1) EP1220911B1 (de)
JP (2) JP2003510071A (de)
AT (1) ATE346924T1 (de)
AU (1) AU785363B2 (de)
CA (1) CA2384981A1 (de)
DE (1) DE60032161D1 (de)
WO (1) WO2001023540A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1290028B1 (de) * 2000-06-05 2009-12-23 The Brigham And Women's Hospital, Inc. Für ein homologes des humanen, für mehrfachresistenz verantwortlichen, p-glykoproteins auf chromosom 7p15-21 kodierendes gen sowie verwendungen dafür
AU2002367884A1 (en) * 2001-03-19 2002-10-03 Gentest Corporation P-Glycoproteins and uses thereof
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
US20110287034A1 (en) 2008-11-14 2011-11-24 The Brigham And Womens Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
EP3784249A4 (de) 2018-04-25 2022-03-02 Children's Medical Center Corporation Abcb5-liganden und -substrate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0646171A4 (de) * 1992-05-22 1998-01-07 Us Health Eine verbesserte methode zur expression von menschlichen "multidrug-resistance" genen und eine verbesserte selektion für zellen welche mit diesen genen transduziert wurden.
US5830697A (en) * 1997-01-21 1998-11-03 The Board Of Trustees Of The Leland Stanford Junior University P-glycoprotein mutant resistant to cyclosporin modulation

Also Published As

Publication number Publication date
WO2001023540A3 (en) 2001-10-18
CA2384981A1 (en) 2001-04-05
WO2001023540A2 (en) 2001-04-05
JP2012061008A (ja) 2012-03-29
AU785363B2 (en) 2007-02-01
EP1220911A2 (de) 2002-07-10
DE60032161D1 (de) 2007-01-11
EP1220911B1 (de) 2006-11-29
JP2003510071A (ja) 2003-03-18
AU7732700A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
CY1106708T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
ATE377597T1 (de) Anilinochinazoline als protein-tyrosin- kinasehemmer
DE60021282D1 (de) Carbamat-derivate als muscarin-rezeptor antonisten
PT966465E (pt) Inibidores do enzima imfdh
ATE469151T1 (de) Pyrrolopyridinderivate als proteinkinaseinhibitoren
NO20001598L (no) Apolipoprotein A-1-agonister og deres anvendelse for Õ behandle dyslipidemiske forstyrrelser
WO2002089738A3 (en) Proteomimetic compounds and methods
ATE300533T1 (de) 1,2,3,4-tetrahydroisochinolin-derivate als urotensin ii rezeptor-antagonisten
JO2534B1 (en) Pyrimidines carrying alternatives of sulfoximine as CDK and / or VEGF inhibitors and their production and use as pharmaceutical agents
MA29088B1 (fr) Composes d'indazole-carboxamide.
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
ATE312090T1 (de) 4-(piperidyl- und pyrrolidyl-alkyl-ureido)- chinoline als urotensin ii rezeptor antagonisten
SE0202598D0 (sv) Alpha-7 Nicotinic receptor agonists and statins in combination
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
WO2004043383A3 (en) A new target for angiogenesis and anti-angiogenesis therapy
ATE549353T1 (de) Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen
NO20055209D0 (no) Peptabody for cancerbehandling
DK1234025T3 (da) Humane enzymer fra metalloproteasefamilien
ATE266722T1 (de) Zyklische peptidomimetische urokinaserezeptorantagonisten
DE60032161D1 (de) P-glycoproteine und ihre verwendungen
DE59809283D1 (de) Inhibitoren für den urokinaserezeptor
DE60015187D1 (de) Urotensin-ii rezeptorantagonisten
EP1293567A4 (de) Gpr8 ligand und dafuer kodierende dna(02.01.02)
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties